CN104583236A - 高度多样的组合抗体文库 - Google Patents

高度多样的组合抗体文库 Download PDF

Info

Publication number
CN104583236A
CN104583236A CN201380044638.9A CN201380044638A CN104583236A CN 104583236 A CN104583236 A CN 104583236A CN 201380044638 A CN201380044638 A CN 201380044638A CN 104583236 A CN104583236 A CN 104583236A
Authority
CN
China
Prior art keywords
antibody
library
human
families
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380044638.9A
Other languages
English (en)
Chinese (zh)
Inventor
约翰内斯·约斯夫·威廉默斯·德哈德
克里斯托夫·弗雷德里克·杰罗姆·布朗什托
亚历克斯·克拉伦比克
伊克贝尔·阿舒尔
哈利尔·埃尔马祖阿里
于尔根·德尔法韦罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ArgenX SE
Original Assignee
ArgenX SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ArgenX SE filed Critical ArgenX SE
Publication of CN104583236A publication Critical patent/CN104583236A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • C07K16/461Igs containing Ig-regions, -domains or -residues form different species
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
CN201380044638.9A 2012-08-31 2013-09-02 高度多样的组合抗体文库 Pending CN104583236A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261695819P 2012-08-31 2012-08-31
US61/695,819 2012-08-31
PCT/EP2013/068110 WO2014033304A2 (en) 2012-08-31 2013-09-02 Highly diverse combinatorial antibody libraries

Publications (1)

Publication Number Publication Date
CN104583236A true CN104583236A (zh) 2015-04-29

Family

ID=49117845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380044638.9A Pending CN104583236A (zh) 2012-08-31 2013-09-02 高度多样的组合抗体文库

Country Status (9)

Country Link
US (1) US10040870B2 (https=)
EP (1) EP2890709A2 (https=)
JP (1) JP6283030B2 (https=)
CN (1) CN104583236A (https=)
AU (1) AU2013310839B2 (https=)
CA (1) CA2879834A1 (https=)
IL (1) IL236524B (https=)
IN (1) IN2015DN00138A (https=)
WO (1) WO2014033304A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110139952A (zh) * 2016-12-09 2019-08-16 深圳华大生命科学研究院 骆驼科抗体可变区免疫组库构建的引物组合及应用

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201792573A1 (ru) 2015-05-21 2018-04-30 Харпун Терапьютикс, Инк. Триспецифические связанные белки и способы их применения
US11623958B2 (en) 2016-05-20 2023-04-11 Harpoon Therapeutics, Inc. Single chain variable fragment CD3 binding proteins
JP7101621B2 (ja) 2016-05-20 2022-07-15 ハープーン セラピューティクス,インク. 単一ドメイン血清アルブミン結合タンパク質
CN116987189A (zh) 2016-05-20 2023-11-03 哈普恩治疗公司 单链可变片段cd3结合蛋白质
AU2017292184A1 (en) 2016-07-08 2019-02-07 Staten Biotechnology B.V. Anti-Apoc3 antibodies and methods of use thereof
EP3544629A4 (en) * 2016-11-23 2020-06-17 Harpoon Therapeutics, Inc. PSMA TO BE TRISPECIFIC PROTEINS AND METHOD FOR USE THEREOF
CN110198955A (zh) 2016-11-23 2019-09-03 哈普恩治疗公司 前列腺特异性膜抗原结合蛋白质
EP3589662A4 (en) 2017-02-28 2020-12-30 Harpoon Therapeutics, Inc. INDUCTIBLE MONOVALENT ANTIGEN BINDING PROTEIN
JP2020517242A (ja) 2017-04-21 2020-06-18 スターテン・バイオテクノロジー・ベー・フェー 抗ApoC3抗体およびその使用方法
WO2018209304A1 (en) 2017-05-12 2018-11-15 Harpoon Therapeutics, Inc. Msln targeting trispecific proteins and methods of use
AU2018265856B2 (en) 2017-05-12 2023-04-27 Harpoon Therapeutics, Inc. Mesothelin binding proteins
HRP20241268T1 (hr) 2017-10-13 2024-12-06 Harpoon Therapeutics, Inc. Trispecifični proteini i postupci primjene
IL315737A (en) 2017-10-13 2024-11-01 Harpoon Therapeutics Inc B-cell maturation antigen-binding proteins
US10538583B2 (en) 2017-10-31 2020-01-21 Staten Biotechnology B.V. Anti-APOC3 antibodies and compositions thereof
KR20200074975A (ko) 2017-10-31 2020-06-25 스태튼 바이오테크놀로지 비.브이. 항-ApoC3 항체 및 이의 사용 방법
KR20210020903A (ko) 2018-05-14 2021-02-24 하푼 테라퓨틱스, 인크. 면역글로불린 분자의 조건부 활성화를 위한 결합 모이어티
WO2020061482A1 (en) 2018-09-21 2020-03-26 Harpoon Therapeutics, Inc. Egfr binding proteins and methods of use
SG11202103022WA (en) 2018-09-25 2021-04-29 Harpoon Therapeutics Inc Dll3 binding proteins and methods of use
US12516128B2 (en) 2019-05-14 2026-01-06 Harpoon Therapeutics, Inc. EpCAM binding proteins and methods of use
CA3170833A1 (en) 2020-02-21 2021-08-26 Harpoon Therapeutics, Inc. Flt3 binding proteins and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102216328A (zh) * 2008-07-02 2011-10-12 阿尔金-X公司 骆驼科动物来源的抗原结合多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US8444976B2 (en) 2008-07-02 2013-05-21 Argen-X B.V. Antigen binding polypeptides
CA2762837C (en) * 2009-05-20 2021-08-03 Novimmune S.A. Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
GB2476681B (en) 2010-01-04 2012-04-04 Argen X Bv Humanized camelid VH, VK and VL immunoglobulin domains

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102216328A (zh) * 2008-07-02 2011-10-12 阿尔金-X公司 骆驼科动物来源的抗原结合多肽

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DARREN J SCHOFIELD等: "Application of phage display to high throughput antibody generation and characterization", 《GENOME BIOLOGY》 *
HANS J. DE HAARD等: "A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110139952A (zh) * 2016-12-09 2019-08-16 深圳华大生命科学研究院 骆驼科抗体可变区免疫组库构建的引物组合及应用
CN110139952B (zh) * 2016-12-09 2022-11-25 深圳华大生命科学研究院 骆驼科抗体可变区免疫组库构建的引物组合及应用

Also Published As

Publication number Publication date
AU2013310839B2 (en) 2017-06-01
WO2014033304A3 (en) 2014-05-01
JP2015526495A (ja) 2015-09-10
JP6283030B2 (ja) 2018-02-21
US10040870B2 (en) 2018-08-07
AU2013310839A1 (en) 2015-01-29
CA2879834A1 (en) 2014-03-06
US20150166680A1 (en) 2015-06-18
IN2015DN00138A (https=) 2015-06-12
IL236524B (en) 2019-01-31
IL236524A0 (en) 2015-02-26
WO2014033304A2 (en) 2014-03-06
EP2890709A2 (en) 2015-07-08

Similar Documents

Publication Publication Date Title
CN104583236A (zh) 高度多样的组合抗体文库
Zhang Evolution of phage display libraries for therapeutic antibody discovery
Parola et al. Integrating high‐throughput screening and sequencing for monoclonal antibody discovery and engineering
Glanville et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire
Shi et al. De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins
US10415033B2 (en) Phage-displayed single-chain variable fragment libraries and uses thereof
Bai et al. A novel human scFv library with non-combinatorial synthetic CDR diversity
BRPI1011195B1 (pt) métodos para produzir uma coleção de ácidos nucleicos
CN104583238A (zh) 用于产生具有物种间、靶标内交叉反应性之抗体分子的方法
Liu et al. Research progress on unique paratope structure, antigen binding modes, and systematic mutagenesis strategies of single-domain antibodies
JP7332691B2 (ja) 抗体の開発可能性が最大化された抗体ライブラリー
Erasmus et al. A single donor is sufficient to produce a highly functional in vitro antibody library
JP7086856B2 (ja) 免疫レパートリー発掘
Spiliotopoulos et al. Sensitive recovery of recombinant antibody clones after their in silico identification within NGS datasets
US12258679B2 (en) Polyclonal mixtures of antibodies, and methods of making and using them
Venet et al. Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences
Chen et al. Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens
Hamidon et al. Immune TB antibody phage display library as a tool to study B cell immunity in TB infections
JP6665274B2 (ja) 標的分子に結合するポリペプチドの決定方法及び決定システム
Nathan et al. Phage display of recombinant antibodies toward Burkholderia pseudomallei exotoxin
US10745696B2 (en) HC-CDR3-only libraries with reduced combinatorial redundancy and optimized loop length distribution
Gueneau et al. Round optimization for improved discovery of native bispecific antibodies
Leow et al. Monoclonal IgY antibodies
WO2025098470A1 (en) Natural and artificial intelligent methods for discovering humanlike nanobodies with low immunogenicity
유덕균 Prediction of antigen binding reactivity using supervised learning on clonal enrichment pattern through bio-panning

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Holland Breda

Applicant after: Alkings Co.

Address before: Holland Breda

Applicant before: ARGEN-X B.V.

CB02 Change of applicant information
TA01 Transfer of patent application right

Effective date of registration: 20180116

Address after: Belgium zwijnaarde

Applicant after: ARGEN-X B.V.

Address before: Holland Breda

Applicant before: Alkings Co.

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20150429

RJ01 Rejection of invention patent application after publication